<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164682">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01728597</url>
  </required_header>
  <id_info>
    <org_study_id>CMR-12-TECH-02</org_study_id>
    <nct_id>NCT01728597</nct_id>
  </id_info>
  <brief_title>Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols</brief_title>
  <acronym>CMR-TECH</acronym>
  <official_title>Optimization of Non-contrast Enhanced 1.5 Tesla and 3 Tesla Cardiac Magnetic Resonance Imaging Techniques and Acquisition of Normal Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amt der Steiermärkischen Landesregierung, Abteilung 3</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the main problems in cardiac magnetic resonance (MR) investigations is the strong
      dependence of the achieved image quality on optimal settings of sequence parameters and
      anatomical and physiological situations and it is well known that the diagnostic impact of
      cardiac MR investigations crucially depends on the adaption of imaging protocols to
      patients' state and ability to cooperate.

      The aim of the present study is the evaluation and optimization of various 1.5 Tesla and 3
      Tesla cardiac MR investigation protocols without application of contrast agent as well as
      the acquisition of normal values for new cardiac MR images techniques:

        -  normal myocardial morphology: T1-, T2- and T2*-weighted imaging and acquisition of
           normal values of magnetic relaxation times (sequence- and protocol dependent),

        -  normal cardiac function: systolic and diastolic function (sequence- and protocol
           dependent),

        -  coronary artery imaging: feasibility to evaluate length, diameter and blood flow
           (sequence- and protocol dependent),

        -  normal blood flow topologies in the heart and the surrounding great vessels: 2D- and 3D
           blood flow imaging and evaluation techniques (sequence- and protocol dependent).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>cardiac volumes</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>volumes of cardiac chambers in the cardiac cycle [ml], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac performance</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>ejection fraction of cardiac chambers [%], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac muscle mass</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>systolic and end-diastolic mass of cardiac chambers [g], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coronary artery anatomy</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>length and diameter [mm], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow velocity</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>maximum, minimum and average velocity [cm/s], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow vorticity</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>number of vortices of blood flow in the heart and surrounding great vessels, sequence and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow timing</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>time points of characteristic blood flow patterns in the heart and surrounding great vessels in the cardiac cycle [ms], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>magnetic relaxation times</measure>
    <time_frame>up to 1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>systolic and diastolic T1, T2, T2* [ms], sequence- and protocol dependent</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <description>MR compliant volunteers with no history of cardiovascular diseases</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No history of cardiac or pulmonary diseases

          -  ability to give informed consent

        Exclusion Criteria:

          -  General MR exclusion criteria eg. patients with metal devices or other magnetic
             material in or on the subjects body which will be hazardous for MR investigation
             (e.g. heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile
             implants, coloured contact lenses, patch to deliver medications through the skin, any
             metal implants as rods, joints, plates, pins, screws, nails or clips, embolization
             coil, or any metal fragments or shrapnel in the body),

          -  pregnancy,

          -  claustrophobia.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Reiter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ursula Reiter, PhD</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>83347</phone_ext>
    <email>ursula.reiter@klinikum-graz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>2411</phone_ext>
    <email>michael.fuchsjaeger@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>2411</phone_ext>
      <email>michael.fuchsjaeger@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Ursula Reiter, PhD</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>83347</phone_ext>
      <email>ursula.reiter@klinikum-graz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Ursula Reiter, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gert Reiter, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph Maderthaner, OA Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helmut Schöllnast, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franz Ebner, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <results_reference>
    <citation>Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal Diastolic and Systolic Myocardial T1 Values at 1.5-T MR Imaging: Correlations and Blood Normalization. Radiology. 2013 Dec 6:131225. [Epub ahead of print]</citation>
    <PMID>24475837</PMID>
  </results_reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 29, 2014</lastchanged_date>
  <firstreceived_date>November 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Ursula Reiter</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>no history of cardiovascular diseases</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
